CNS Drugs Journal Issues Research Articles in December 2024 Edition
November 25, 2024
November 25, 2024
BERLIN, Germany, Nov. 25 -- CNS Drugs, a peer-reviewed journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its December 2024 edition (Vol. 38, Issue 12):
* A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients wi . . .
* A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients wi . . .